Lexology July 15, 2025
The Federal Trade Commission announced that it reached a settlement with telemedicine company NextMed, resolving allegations that the company misled consumers about its weight loss programs. As part of the settlement, the company agreed to pay $150,000.
The FTC alleged that NextMed promoted the availability of its weight loss programs for a monthly fee (typically for $138 or $188), but failed to adequately disclose the fact that the fee didn’t include the cost of the weight loss medication, the cost of the lab work that was necessary to determine eligibility for the medication, or the fee for the required doctor visit. In addition, the FTC alleged that NextMed also didn’t properly disclose that its weight loss programs required a one-year...
Today's Sponsors
Today's Sponsor